SEC Form 4 · accession 0000899243-15-008118
Marker Therapeutics, Inc. · MRKR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David Laskow-Pooley
Director
Period of report
Mar 19, 2015
Accepted (ET)
Nov 13, 2015 · 4:06 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001094038
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F1 | $0.21 | Mar 19, 2015 | A | 150,000 | A | — | Mar 19, 2025 | Common Stock | 150,000 | 150,000 | D |
Explanation of responses
- F1Represents options granted in connection with appointment as a director of the Company on March 19, 2015 under the Company's 2014 Omnibus Stock Ownership Plan. These shares shall vest monthly over a two year period. The option exercise price is the closing price on the date of the grant, March 19, 2015.